Rare diseases
Investigational molecules
Locations
Back to Portugal679 clinical trials in Senhora Da Hora, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Study on the Effects of Rusfertide (PTG-300) for Patients with Polycythemia Vera
PortugalStudy Comparing Bortezomib, Lenalidomide, and Dexamethasone with Ciltacabtagene Autoleucel for Newly Diagnosed Multiple Myeloma Patients Not Planning Stem Cell Transplant
PortugalLong-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
PortugalStudy of [177Lu]Lu-NeoB and Capecitabine for Patients with Advanced Breast Cancer Resistant to Hormone Therapy
PortugalStudy of Tucatinib, Trastuzumab, and Pertuzumab for Patients with Advanced or Metastatic HER2+ Breast Cancer
PortugalStudy of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced or Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations
PortugalStudy on Atezolizumab for Patients with Non-Small Cell Lung Cancer After Chemotherapy
PortugalStudy on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis
PortugalStudy on Long-Term Safety of Itepekimab for Patients with Chronic Obstructive Pulmonary Disease (COPD)
PortugalStudy on Epcoritamab, Rituximab, and Lenalidomide for Adults with Untreated Follicular Lymphoma
PortugalStudy of Lenvatinib and Pembrolizumab for Patients with Recurrent or Metastatic Head and Neck Cancer After Platinum and Immunotherapy Treatment
PortugalStudy on Isatuximab, Carfilzomib, and Dexamethasone for Adults with Relapsed or Refractory Multiple Myeloma
PortugalThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Alzheimer's disease and associated conditions, including studies on psychosis treatment and cognitive decline prevention. Multiple trials exploring migraine prevention with novel therapeutic approaches.
Studies are evaluating both symptomatic relief and disease modification strategies.
Comprehensive research in breast cancer treatments, particularly focusing on HR+/HER2- variants and innovative combination therapies. Advanced studies in non-small cell lung cancer exploring new treatment paradigms.
Trials emphasize targeted therapies and immunotherapy approaches.
Groundbreaking research in severe asthma management and chronic rhinosinusitis. Studies evaluating new treatments for COPD with focus on long-term safety and efficacy.
Emphasis on innovative inhaler combinations and targeted biological treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
